| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716768 | Null | 0.0115521552688258 | 0.0047891151 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0115521552688258 | -0.23551605 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0115521552688258 | -0.19066594 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0115521552688258 | 0.35757033 |
| NSC 735540 | 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide | 0.0115521552688258 | -0.21347592 |
| NSC 736164 | pyrazoline derivative | 0.0115521552688258 | -0.29539487 |
| NSC 747452 | 3,19-(4-Acetamido)benzylidineandrographolide | 0.0115521552688258 | -0.22394611 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0115521552688258 | -0.26443076 |
| NSC 88054 | Null | 0.0115521552688258 | -0.26920263 |
| NSC 100290 | Doxypyrromycin hydrochloride | 0.0123744972338278 | -0.072109241 |